← All stories
Tech
GSK (LSE:GSK) approval news tests how blue-chip healthcare absorbs innovation
Highlights A Japanese regulatory decision made Hibsago GSKs first approved chronic hepatitis treatment in any market. The shares softened early, showing that positive regulation and immediate market performance can diverge. Blue-chip resear…
Covered by 1 outlet
All coverage · 1 article